SBRT Followed by Neoadjuvant Immunochemotherapy in Resectable Stage II to III Non-small Cell Lung Cancer
Clinical trial NCT05319574 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05319574
- Sponsor
- Sun Yat-sen University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-24
- Primary completion
- 2023-06-25
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.